CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Amortization	$ 160,625	$ 160,625	$ 185,271
Technology Impairment Charge	0	0	345,000
Depreciation	10,284	0	0
Research and Development Expense [Member]
Equity compensation	83,139	32,879	53,645
Amortization	160,625	160,625	185,271
General and Administrative Expense [Member]
Stock option and warrant expense	$ 321,011	$ 671,601	$ 9,740